logo

For the Inventor, By the Inventor

Paris, France

Fabienne Sounigo-Thompson

This inventor holds 4 USPTO granted patents. Top assignees: Rhone-Poulenc Rorer S.a., Aventis Pharma S.a., Rhone-Poulenc S.a.. Active years: 1999-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fabienne Sounigo-Thompson. Retrieved from https://idiyas.com/inventor/fabienne-sounigo-thompson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 7.7

ph-index = 3

Forward Citations = 60(Granted Patents)


Company Filing History:

goldMedal2 out of 247 
 
Rhone-Poulenc Rorer S.a.
 patents
silverMedal1 out of 377 
 
Aventis Pharma S.a.
 patents
bronzeMedal1 out of 142 
 
Rhone-Poulenc S.a.
 patents

Years Active: 1999-2001

Loading Chart...
4 patents (USPTO):Explore Patents
1. 6218406 - Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments (2001-04-17),
2. 6124465 - Farnesyl transferase inhibitors, their preparation, the pharmaceutical (2000-09-26),
3. 6013662 - Farnesyl transferase inhibitors, their preparation, the pharmaceutical (2000-01-11),
4. 5936097 - 4,9-ethano-benzo(F)isoindole derivatives as farnesyl transferase (1999-08-10),

Title: Fabienne Sounigo-Thompson: Innovator in Farnesyl Transferase Inhibitors

Introduction

Fabienne Sounigo-Thompson is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of farnesyl transferase inhibitors. With a total of 4 patents to her name, her work has garnered attention for its potential therapeutic applications.

Latest Patents

Her latest patents focus on farnesyl transferase inhibitors, detailing their preparation, pharmaceutical compositions, and uses in medicaments. The innovative products she has developed include novel compounds represented by specific formulas, which exhibit notable antitumor and antileukemic properties. These compounds are characterized by various substituents that enhance their efficacy and application in medical treatments.

Career Highlights

Throughout her career, Fabienne has worked with notable companies such as Rhone-Poulenc Rorer S.A. and Rhone-Poulenc S.A. Her expertise in pharmaceutical research has positioned her as a key figure in the development of new therapeutic agents.

Collaborations

She has collaborated with esteemed colleagues, including Patrick Mailliet and Alain Commercedillaon, contributing to the advancement of her research and innovations.

Conclusion

Fabienne Sounigo-Thompson's work in the field of farnesyl transferase inhibitors highlights her role as a leading inventor in pharmaceutical innovation. Her contributions continue to pave the way for new treatments in oncology and hematology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…